Related Experiment Video
Updated: Aug 20, 2025

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
The Development of Investigator-Initiated Clinical Trials in Surgical Oncology
Hannah G McDonald1, Emily B Cassim1, Megan M Harper1
1Division of Surgical Oncology, University of Kentucky, 800 Rose Street C224, Lexington, KY 40508, USA.
Abstract:
Investigator-initiated trials (IITs) are designed by principal investigators who identify important, unaddressed clinical gaps and opportunities to answer these questions through clinical trials. Surgical oncologists are poised to lead IITs due to their multidisciplinary clinical practice and substantial research background. The process of developing, organizing, and implementing IITs is multifaceted and involves important steps including (but not limited to) navigating regulatory requirements, obtaining funding, and meeting enrollment targets. Here, the authors explore the steps, methodology, and barriers of IIT development by surgical oncologists and highlight the importance of IITs in oncology.
Insights
Surgical oncologists can lead investigator-initiated trials (IITs) to address clinical gaps. Developing these oncology trials involves regulatory navigation, funding, and enrollment, highlighting IITs' crucial role.
Area of Science:
- Oncology
- Clinical Trials
- Surgical Oncology
Background:
- Investigator-initiated trials (IITs) address unmet clinical needs identified by principal investigators.
- Surgical oncologists are well-positioned to lead IITs due to their clinical expertise and research experience.
Purpose of the Study:
- To explore the process, methodology, and challenges of developing IITs by surgical oncologists.
- To emphasize the significance of IITs in advancing oncology research and patient care.
Main Methods:
- Review of the multifaceted process of IIT development.
- Identification of key steps: regulatory navigation, funding acquisition, and participant enrollment.
Main Results:
- IIT development is complex, requiring careful planning and execution.
- Surgical oncologists possess the necessary skills to lead these critical research endeavors.
Conclusions:
- IITs are vital for addressing critical gaps in oncology.
- Surgical oncologists play a pivotal role in driving innovative clinical research through IITs.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview

